(CORT) Corcept Therapeutics - Performance 174.7% in 12m
Compare CORT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
84.27%
#2 in Group
Rel. Strength
98.30%
#137 in Universe
Total Return 12m
174.67%
#6 in Group
Total Return 5y
404.79%
#8 in Group
P/E 55.8
88th Percentile in Group
P/E Forward 41.0
81th Percentile in Group
PEG 0.61
33th Percentile in Group
FCF Yield 2.85%
93th Percentile in Group
12m Total Return: CORT (174.7%) vs XLV (-0.5%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
10.2% | 175% | 405% | 55.8 | 41 | 0.61 | 61.4% | 10.7% |
LLY NYSE Eli Lilly |
2.12% | 13.3% | 466% | 62.7 | 31.5 | 1.05 | 40.3% | 34.5% |
NVS NYSE Novartis |
-1.21% | 24.1% | 59.8% | 18 | 12.9 | 1.23 | 36.2% | 11% |
SFZN SW Siegfried Holding |
-2.09% | 1.78% | 95.3% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
SUPN NASDAQ Supernus Pharmaceuticals |
-4.71% | 6.55% | 74.3% | 24 | 20.2 | 1.47 | -20.8% | -17% |
SOBI ST Swedish Orphan Biovitrum |
-8.43% | 1.39% | 42.8% | 23.3 | 18.7 | 1.44 | 11.8% | 14.7% |
SAN PA Sanofi |
-15.7% | 10.9% | 24.2% | 21.9 | 11.6 | 0.93 | -22.1% | -24.8% |
NOVN SW Novartis |
-7.92% | 11.1% | 33.1% | 17.9 | 12.8 | 1.22 | 36.2% | 11.2% |
Performance Comparison: CORT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CORT
Total Return (including Dividends) | CORT | XLV | S&P 500 |
---|---|---|---|
1 Month | 10.16% | -7.37% | -5.89% |
3 Months | 1.85% | -4.55% | -12.45% |
12 Months | 174.67% | -0.54% | 6.72% |
5 Years | 404.79% | 46.59% | 101.06% |
Trend Score (consistency of price movement) | CORT | XLV | S&P 500 |
1 Month | 35.7% | -82.6% | -74.5% |
3 Months | 8.70% | -37.8% | -88.2% |
12 Months | 94.6% | -1.6% | 66.1% |
5 Years | 74.8% | 90.1% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #8 | 18.9% | 17.1% |
3 Month | #37 | 6.71% | 16.3% |
12 Month | #6 | 176% | 157% |
5 Years | #7 | 244% | 151% |
FAQs
Does CORT Corcept Therapeutics outperforms the market?
Yes,
over the last 12 months CORT made 174.67%, while its related Sector, the Health Care Sector SPDR (XLV) made -0.54%.
Over the last 3 months CORT made 1.85%, while XLV made -4.55%.
Over the last 3 months CORT made 1.85%, while XLV made -4.55%.
Performance Comparison CORT vs Indeces and Sectors
CORT vs. Indices CORT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -7.89% | 16.1% | 34.5% | 168% |
US NASDAQ 100 | QQQ | -7.03% | 16.4% | 35.0% | 169% |
US Dow Jones Industrial 30 | DIA | -6.72% | 16.0% | 34.0% | 169% |
German DAX 40 | DAX | -13.3% | 19.6% | 17.4% | 156% |
Shanghai Shenzhen CSI 300 | CSI 300 | -8.60% | 17.7% | 32.2% | 169% |
Hongkong Hang Seng | HSI | -12.2% | 20.0% | 33.0% | 158% |
India NIFTY 50 | INDA | -12.3% | 5.39% | 32.0% | 172% |
Brasil Bovespa | EWZ | -11.5% | 15.2% | 31.5% | 184% |
CORT vs. Sectors CORT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -8.14% | 15.8% | 25.7% | 161% |
Consumer Discretionary | XLY | -7.02% | 14.1% | 31.8% | 165% |
Consumer Staples | XLP | -11.2% | 6.96% | 24.3% | 161% |
Energy | XLE | -12.6% | 20.2% | 33.4% | 185% |
Financial | XLF | -9.26% | 14.7% | 26.4% | 156% |
Health Care | XLV | -8.29% | 17.5% | 35.9% | 175% |
Industrial | XLI | -9.01% | 14.9% | 34.4% | 169% |
Materials | XLB | -9.61% | 16.8% | 41.6% | 182% |
Real Estate | XLRE | -13.2% | 13.1% | 33.1% | 158% |
Technology | XLK | -6.53% | 19.1% | 41.3% | 176% |
Utilities | XLU | -11.2% | 10.6% | 28.8% | 150% |
Aerospace & Defense | XAR | -9.58% | 10.1% | 24.7% | 151% |
Biotech | XBI | -11.5% | 22.0% | 49.0% | 184% |
Homebuilder | XHB | -8.84% | 17.0% | 52.4% | 184% |
Retail | XRT | -9.59% | 12.3% | 39.2% | 179% |